StockData

Femasys Inc (FEMY) stock

FEMYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/3035% below fair value
$1.15+0.03 (+2.68%)

Close on Nov 18, 2026Market cap $9.63MP/E –Yield –

Femasys gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Femasys's gross profit for the twelve months ending Jun 30, 2026 was $1.40M, up 14.1% year over year. For fiscal 2025 it was $1.42M, up 31.1% from the year before. The highest annual figure on record is $1.42M in fiscal 2025.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.42M+31.1%
FY2024Dec 31, 2024$1.08M+56.7%
FY2023Dec 31, 2023$691.90K-9.5%
FY2022Dec 31, 2022$764.28K-5.6%
FY2021Dec 31, 2021$809.31K+10.7%
FY2020Dec 31, 2020$731.39K–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$189.39K-24.6%
Q1 FY2026Mar 31, 2026$266.28K+18.9%
Q4 FY2025Dec 31, 2025$510.26K+31.1%
Q3 FY2025Sep 30, 2025$435.56K+19.6%
Q2 FY2025Jun 30, 2025$251.10K+69.2%
Q1 FY2025Mar 31, 2025$224.00K+22.7%
Q4 FY2024Dec 31, 2024$389.17K+188.7%
Q3 FY2024Sep 30, 2024$364.07K+130.2%
Q2 FY2024Jun 30, 2024$148.36K-29.4%
Q1 FY2024Mar 31, 2024$182.61K-3.3%
Q4 FY2023Dec 31, 2023$134.82K-9.4%
Q3 FY2023Sep 30, 2023$158.18K-26.8%
Q2 FY2023Jun 30, 2023$210.05K+4.6%
Q1 FY2023Mar 31, 2023$188.86K-5.0%
Q4 FY2022Dec 31, 2022$148.79K-21.7%
Q3 FY2022Sep 30, 2022$216.01K+31.6%
Q2 FY2022Jun 30, 2022$200.76K-8.1%
Q1 FY2022Mar 31, 2022$198.73K-16.1%
Q4 FY2021Dec 31, 2021$190.02K-1.7%
Q3 FY2021Sep 30, 2021$164.18K-26.3%
Q2 FY2021Jun 30, 2021$218.38K+70.7%
Q1 FY2021Mar 31, 2021$236.73K–
Q4 FY2020Dec 31, 2020$193.33K–
Q3 FY2020Sep 30, 2020$222.77K–
Q2 FY2020Jun 30, 2020$127.96K–

More Femasys figures

See a number that looks wrong?